

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular response to type I interferon (GO:0071357) | 5.93174287 |
| 2 | type I interferon signaling pathway (GO:0060337) | 5.93174287 |
| 3 | response to type I interferon (GO:0034340) | 5.92354085 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.52741981 |
| 5 | positive regulation of interferon-alpha production (GO:0032727) | 5.34123407 |
| 6 | response to interferon-alpha (GO:0035455) | 5.20141335 |
| 7 | regulation of interferon-alpha production (GO:0032647) | 5.02682612 |
| 8 | response to peptidoglycan (GO:0032494) | 4.87237980 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.85325775 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.85325775 |
| 11 | regulation of RIG-I signaling pathway (GO:0039535) | 4.83374214 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.79818543 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.79818543 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.79818543 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 4.79818543 |
| 16 | positive regulation by symbiont of host defense response (GO:0052509) | 4.79818543 |
| 17 | modulation by symbiont of host defense response (GO:0052031) | 4.79818543 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.58459652 |
| 19 | negative regulation of viral genome replication (GO:0045071) | 4.52922320 |
| 20 | cellular response to interferon-beta (GO:0035458) | 4.45731260 |
| 21 | neutrophil activation involved in immune response (GO:0002283) | 4.29975004 |
| 22 | T-helper 1 type immune response (GO:0042088) | 4.23432642 |
| 23 | negative regulation of interleukin-12 production (GO:0032695) | 4.15877255 |
| 24 | cellular response to exogenous dsRNA (GO:0071360) | 4.14745484 |
| 25 | regulation of chronic inflammatory response (GO:0002676) | 4.12027067 |
| 26 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 4.10606075 |
| 27 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.04551520 |
| 28 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.01284184 |
| 29 | response to interferon-beta (GO:0035456) | 3.98236602 |
| 30 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.96128551 |
| 31 | negative regulation of cell killing (GO:0031342) | 3.96128551 |
| 32 | cellular response to interferon-alpha (GO:0035457) | 3.94893684 |
| 33 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.88377384 |
| 34 | immunoglobulin mediated immune response (GO:0016064) | 3.84585783 |
| 35 | response to host immune response (GO:0052572) | 3.82944686 |
| 36 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.82944686 |
| 37 | regulation of activation of Janus kinase activity (GO:0010533) | 3.79104098 |
| 38 | positive regulation of interferon-beta production (GO:0032728) | 3.77710323 |
| 39 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.76923820 |
| 40 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.74119882 |
| 41 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.72192322 |
| 42 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.68971718 |
| 43 | regulation of viral genome replication (GO:0045069) | 3.67455998 |
| 44 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.66485541 |
| 45 | positive regulation of type 2 immune response (GO:0002830) | 3.64384007 |
| 46 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.61212909 |
| 47 | defense response to virus (GO:0051607) | 3.60267905 |
| 48 | positive regulation of interleukin-17 production (GO:0032740) | 3.59115944 |
| 49 | T cell migration (GO:0072678) | 3.59077173 |
| 50 | negative regulation of viral process (GO:0048525) | 3.56869212 |
| 51 | positive regulation of antigen processing and presentation (GO:0002579) | 3.56066233 |
| 52 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.55174262 |
| 53 | granulocyte activation (GO:0036230) | 3.54647285 |
| 54 | cellular response to virus (GO:0098586) | 3.54015631 |
| 55 | negative regulation of T cell mediated immunity (GO:0002710) | 3.53854189 |
| 56 | neutrophil activation (GO:0042119) | 3.53776654 |
| 57 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.51200798 |
| 58 | natural killer cell mediated immunity (GO:0002228) | 3.51200798 |
| 59 | macrophage activation involved in immune response (GO:0002281) | 3.50993191 |
| 60 | defense response to protozoan (GO:0042832) | 3.49721428 |
| 61 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.48929550 |
| 62 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.48068051 |
| 63 | negative regulation of type I interferon production (GO:0032480) | 3.40675363 |
| 64 | positive regulation of interleukin-12 production (GO:0032735) | 3.39240902 |
| 65 | response to muramyl dipeptide (GO:0032495) | 3.33783941 |
| 66 | regulation of type 2 immune response (GO:0002828) | 3.33587906 |
| 67 | positive regulation of defense response to virus by host (GO:0002230) | 3.33394407 |
| 68 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.32194119 |
| 69 | superoxide anion generation (GO:0042554) | 3.31637506 |
| 70 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.30373937 |
| 71 | respiratory burst (GO:0045730) | 3.29631273 |
| 72 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.29530159 |
| 73 | microglial cell activation (GO:0001774) | 3.29344637 |
| 74 | response to host (GO:0075136) | 3.28775125 |
| 75 | response to host defenses (GO:0052200) | 3.28775125 |
| 76 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.28775125 |
| 77 | positive regulation of response to biotic stimulus (GO:0002833) | 3.28680731 |
| 78 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.28381169 |
| 79 | positive regulation of T cell cytokine production (GO:0002726) | 3.26981899 |
| 80 | regulation of antigen processing and presentation (GO:0002577) | 3.26448150 |
| 81 | cellular response to interferon-gamma (GO:0071346) | 3.22933970 |
| 82 | NIK/NF-kappaB signaling (GO:0038061) | 3.20838841 |
| 83 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.18469517 |
| 84 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.17684848 |
| 85 | natural killer cell activation involved in immune response (GO:0002323) | 3.13735735 |
| 86 | regulation of chemokine biosynthetic process (GO:0045073) | 3.12541055 |
| 87 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.12133686 |
| 88 | mature B cell differentiation (GO:0002335) | 3.11501958 |
| 89 | detection of other organism (GO:0098543) | 3.08694927 |
| 90 | regulation of vitamin metabolic process (GO:0030656) | 3.08480066 |
| 91 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.07771002 |
| 92 | myeloid cell activation involved in immune response (GO:0002275) | 3.07758423 |
| 93 | regulation of interleukin-17 production (GO:0032660) | 3.07235632 |
| 94 | I-kappaB phosphorylation (GO:0007252) | 3.06569040 |
| 95 | positive regulation of heat generation (GO:0031652) | 3.05881668 |
| 96 | regulation of defense response to virus by host (GO:0050691) | 3.05527121 |
| 97 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.04837704 |
| 98 | interferon-gamma secretion (GO:0072643) | 3.03353348 |
| 99 | myeloid dendritic cell differentiation (GO:0043011) | 3.02741598 |
| 100 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.02160442 |
| 101 | response to protozoan (GO:0001562) | 3.00050373 |
| 102 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.99964716 |
| 103 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.97839036 |
| 104 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.97212583 |
| 105 | germinal center formation (GO:0002467) | 2.95910928 |
| 106 | positive regulation of isotype switching (GO:0045830) | 2.94800147 |
| 107 | lymphocyte chemotaxis (GO:0048247) | 2.94550845 |
| 108 | B cell mediated immunity (GO:0019724) | 2.94104804 |
| 109 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.93880287 |
| 110 | regulation of T cell tolerance induction (GO:0002664) | 2.93425877 |
| 111 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.92380797 |
| 112 | monocyte chemotaxis (GO:0002548) | 2.91684276 |
| 113 | detection of molecule of bacterial origin (GO:0032490) | 2.91637825 |
| 114 | positive regulation of humoral immune response (GO:0002922) | 2.91623891 |
| 115 | regulation of gamma-delta T cell activation (GO:0046643) | 2.89331831 |
| 116 | response to interferon-gamma (GO:0034341) | 2.88980789 |
| 117 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.88966596 |
| 118 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 2.88536822 |
| 119 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 2.88536822 |
| 120 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.88385375 |
| 121 | regulation of fever generation (GO:0031620) | 2.86997937 |
| 122 | response to exogenous dsRNA (GO:0043330) | 2.86625361 |
| 123 | regulation of interferon-beta production (GO:0032648) | 2.86330180 |
| 124 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.86231594 |
| 125 | negative regulation of interleukin-17 production (GO:0032700) | 2.86031774 |
| 126 | interferon-gamma production (GO:0032609) | 2.84041935 |
| 127 | regulation of memory T cell differentiation (GO:0043380) | 2.83867187 |
| 128 | regulation of interleukin-12 production (GO:0032655) | 2.83115564 |
| 129 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.81802607 |
| 130 | regulation of T-helper cell differentiation (GO:0045622) | 2.81161086 |
| 131 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.81005018 |
| 132 | negative regulation of multi-organism process (GO:0043901) | 2.80405112 |
| 133 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.79584452 |
| 134 | detection of bacterium (GO:0016045) | 2.79438598 |
| 135 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.78887798 |
| 136 | negative regulation of innate immune response (GO:0045824) | 2.78317608 |
| 137 | regulation of response to interferon-gamma (GO:0060330) | 2.76797189 |
| 138 | regulation of podosome assembly (GO:0071801) | 2.73626652 |
| 139 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.73499481 |
| 140 | regulation of immunoglobulin secretion (GO:0051023) | 2.72177152 |
| 141 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.68701545 |
| 142 | cytokine biosynthetic process (GO:0042089) | 2.65916804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.16119109 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.46867725 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 6.46136602 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.27107443 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.57412793 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.98321198 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.75215441 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.11200558 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.92496213 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.82979723 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.78041268 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.72984489 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.50122352 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.41474741 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.37746232 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.25493787 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.20349584 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.15091989 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.06993934 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.00356590 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.90865748 |
| 22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.90815187 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.83038781 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.68758061 |
| 25 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.66088160 |
| 26 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.64708408 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.64329673 |
| 28 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.60911845 |
| 29 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.60093903 |
| 30 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.58901088 |
| 31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.54404723 |
| 32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.53837192 |
| 33 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.46473356 |
| 34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.42823838 |
| 35 | * MYB_26560356_Chip-Seq_TH2_Human | 1.41891858 |
| 36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.40736957 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.39723518 |
| 38 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.39396407 |
| 39 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.37233904 |
| 40 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.37134778 |
| 41 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.36699448 |
| 42 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.35456547 |
| 43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.35112181 |
| 44 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.31885301 |
| 45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30533712 |
| 46 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27447827 |
| 47 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.27387455 |
| 48 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.26066701 |
| 49 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23658914 |
| 50 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.23067668 |
| 51 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.21670610 |
| 52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21285650 |
| 53 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.20159783 |
| 54 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16918556 |
| 55 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.16725787 |
| 56 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.15536461 |
| 57 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.15112983 |
| 58 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.15001647 |
| 59 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.14431917 |
| 60 | * MYB_26560356_Chip-Seq_TH1_Human | 1.13786126 |
| 61 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.10629083 |
| 62 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.09762045 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09328408 |
| 64 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.09106214 |
| 65 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.08798163 |
| 66 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.08336655 |
| 67 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.08104610 |
| 68 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.08085569 |
| 69 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07622220 |
| 70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07604334 |
| 71 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.07127753 |
| 72 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05205362 |
| 73 | MAF_26560356_Chip-Seq_TH1_Human | 1.03905648 |
| 74 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.02822389 |
| 75 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.02529882 |
| 76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02171094 |
| 77 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.01388797 |
| 78 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00985928 |
| 79 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.00959772 |
| 80 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.00252758 |
| 81 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00163739 |
| 82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00115331 |
| 83 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.99663600 |
| 84 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.99142781 |
| 85 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.99142781 |
| 86 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.99142781 |
| 87 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.98231904 |
| 88 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.97371058 |
| 89 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.97271295 |
| 90 | UTX_26944678_Chip-Seq_JUKART_Human | 0.97159192 |
| 91 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96844749 |
| 92 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.94402292 |
| 93 | SPI1_23127762_ChIP-Seq_K562_Human | 0.93722593 |
| 94 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.92808707 |
| 95 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.92749832 |
| 96 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.91211736 |
| 97 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90715485 |
| 98 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.90366035 |
| 99 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89974079 |
| 100 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89427472 |
| 101 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89426890 |
| 102 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.88264069 |
| 103 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.87711076 |
| 104 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.87547627 |
| 105 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.87217747 |
| 106 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87135018 |
| 107 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87127287 |
| 108 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.85647376 |
| 109 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.84840675 |
| 110 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.84595622 |
| 111 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84233984 |
| 112 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83694825 |
| 113 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.83410059 |
| 114 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83174010 |
| 115 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82890765 |
| 116 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82861641 |
| 117 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.82700134 |
| 118 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.82121984 |
| 119 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81470654 |
| 120 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.80993376 |
| 121 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80458438 |
| 122 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.80384502 |
| 123 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.79314607 |
| 124 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78208407 |
| 125 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.77430374 |
| 126 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75794185 |
| 127 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.73613551 |
| 128 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.73371563 |
| 129 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.71774164 |
| 130 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.71620876 |
| 131 | MAF_26560356_Chip-Seq_TH2_Human | 0.71529903 |
| 132 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.71469908 |
| 133 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.71416789 |
| 134 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.70749794 |
| 135 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.70661914 |
| 136 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.70084255 |
| 137 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.69873612 |
| 138 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.69146286 |
| 139 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.68908086 |
| 140 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68252338 |
| 141 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.67983619 |
| 142 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.67983619 |
| 143 | CJUN_26792858_Chip-Seq_BT549_Human | 0.65681531 |
| 144 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.63514091 |
| 145 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.62630237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.04694005 |
| 2 | MP0009785_altered_susceptibility_to | 4.50935838 |
| 3 | MP0003724_increased_susceptibility_to | 4.27302913 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.51201596 |
| 5 | MP0001790_abnormal_immune_system | 3.33416115 |
| 6 | MP0005387_immune_system_phenotype | 3.33416115 |
| 7 | MP0003436_decreased_susceptibility_to | 3.19585300 |
| 8 | MP0005025_abnormal_response_to | 3.17654360 |
| 9 | MP0000685_abnormal_immune_system | 3.15690527 |
| 10 | MP0005000_abnormal_immune_tolerance | 3.13125149 |
| 11 | MP0005671_abnormal_response_to | 3.10279455 |
| 12 | MP0002419_abnormal_innate_immunity | 2.90243560 |
| 13 | MP0006082_CNS_inflammation | 2.90094130 |
| 14 | MP0001800_abnormal_humoral_immune | 2.72301405 |
| 15 | MP0002723_abnormal_immune_serum | 2.66394526 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.64253797 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.47042060 |
| 18 | MP0003303_peritoneal_inflammation | 2.38865792 |
| 19 | MP0001819_abnormal_immune_cell | 2.29901916 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.24886898 |
| 21 | MP0004510_myositis | 2.18815212 |
| 22 | MP0009764_decreased_sensitivity_to | 2.12564225 |
| 23 | MP0002006_tumorigenesis | 2.07768390 |
| 24 | MP0003136_yellow_coat_color | 1.95181312 |
| 25 | MP0002139_abnormal_hepatobiliary_system | 1.87747257 |
| 26 | MP0002166_altered_tumor_susceptibility | 1.85615301 |
| 27 | MP0002277_abnormal_respiratory_mucosa | 1.80863987 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.78704810 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.75724018 |
| 30 | MP0008469_abnormal_protein_level | 1.74648978 |
| 31 | MP0001853_heart_inflammation | 1.74299375 |
| 32 | MP0009840_abnormal_foam_cell | 1.72306029 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.68027175 |
| 34 | MP0000716_abnormal_immune_system | 1.67306690 |
| 35 | MP0005464_abnormal_platelet_physiology | 1.66884371 |
| 36 | MP0004381_abnormal_hair_follicle | 1.64056893 |
| 37 | MP0002405_respiratory_system_inflammati | 1.62505383 |
| 38 | MP0004947_skin_inflammation | 1.60644955 |
| 39 | MP0005058_abnormal_lysosome_morphology | 1.60369515 |
| 40 | MP0005451_abnormal_body_composition | 1.59217758 |
| 41 | MP0005174_abnormal_tail_pigmentation | 1.58371871 |
| 42 | MP0002398_abnormal_bone_marrow | 1.56001848 |
| 43 | MP0003763_abnormal_thymus_physiology | 1.53488572 |
| 44 | MP0002332_abnormal_exercise_endurance | 1.52915619 |
| 45 | MP0000015_abnormal_ear_pigmentation | 1.47855471 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 1.44101684 |
| 47 | MP0002998_abnormal_bone_remodeling | 1.42341594 |
| 48 | MP0008260_abnormal_autophagy | 1.41867082 |
| 49 | MP0005310_abnormal_salivary_gland | 1.40897581 |
| 50 | MP0003448_altered_tumor_morphology | 1.38523856 |
| 51 | MP0002429_abnormal_blood_cell | 1.25926296 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 1.23970158 |
| 53 | MP0000569_abnormal_digit_pigmentation | 1.23262702 |
| 54 | MP0005409_darkened_coat_color | 1.21973379 |
| 55 | MP0000689_abnormal_spleen_morphology | 1.19342820 |
| 56 | MP0000858_altered_metastatic_potential | 1.17853173 |
| 57 | MP0010234_abnormal_vibrissa_follicle | 1.17405353 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 1.17094814 |
| 59 | MP0002722_abnormal_immune_system | 1.12791264 |
| 60 | MP0003075_altered_response_to | 1.12010826 |
| 61 | MP0009763_increased_sensitivity_to | 1.10000300 |
| 62 | MP0005023_abnormal_wound_healing | 1.09250491 |
| 63 | MP0003172_abnormal_lysosome_physiology | 1.07606186 |
| 64 | MP0004782_abnormal_surfactant_physiolog | 1.06509464 |
| 65 | MP0003718_maternal_effect | 1.06475636 |
| 66 | MP0009278_abnormal_bone_marrow | 1.06348969 |
| 67 | MP0005379_endocrine/exocrine_gland_phen | 1.05971098 |
| 68 | MP0001188_hyperpigmentation | 1.05917577 |
| 69 | MP0005397_hematopoietic_system_phenotyp | 1.05472726 |
| 70 | MP0001545_abnormal_hematopoietic_system | 1.05472726 |
| 71 | MP0000343_altered_response_to | 1.03902515 |
| 72 | MP0002163_abnormal_gland_morphology | 1.02058778 |
| 73 | MP0003191_abnormal_cellular_cholesterol | 1.00709730 |
| 74 | MP0005164_abnormal_response_to | 0.99563250 |
| 75 | MP0002254_reproductive_system_inflammat | 0.99535199 |
| 76 | MP0006054_spinal_hemorrhage | 0.95875049 |
| 77 | MP0000372_irregular_coat_pigmentation | 0.87754583 |
| 78 | MP0003690_abnormal_glial_cell | 0.86833690 |
| 79 | MP0005171_absent_coat_pigmentation | 0.86099576 |
| 80 | MP0001501_abnormal_sleep_pattern | 0.82343479 |
| 81 | MP0001542_abnormal_bone_strength | 0.82190784 |
| 82 | MP0003828_pulmonary_edema | 0.80967976 |
| 83 | MP0008874_decreased_physiological_sensi | 0.80527050 |
| 84 | MP0002933_joint_inflammation | 0.80029366 |
| 85 | MP0005390_skeleton_phenotype | 0.79391951 |
| 86 | MP0003879_abnormal_hair_cell | 0.78705069 |
| 87 | MP0005647_abnormal_sex_gland | 0.78524542 |
| 88 | MP0003183_abnormal_peptide_metabolism | 0.76698652 |
| 89 | MP0001873_stomach_inflammation | 0.75356982 |
| 90 | MP0005166_decreased_susceptibility_to | 0.74435976 |
| 91 | MP0000371_diluted_coat_color | 0.72798302 |
| 92 | MP0003950_abnormal_plasma_membrane | 0.71058349 |
| 93 | MP0005395_other_phenotype | 0.70542682 |
| 94 | MP0010352_gastrointestinal_tract_polyps | 0.69987759 |
| 95 | MP0003186_abnormal_redox_activity | 0.67786447 |
| 96 | MP0004808_abnormal_hematopoietic_stem | 0.67673475 |
| 97 | MP0003045_fibrosis | 0.67217394 |
| 98 | MP0000703_abnormal_thymus_morphology | 0.66075051 |
| 99 | MP0005165_increased_susceptibility_to | 0.65844146 |
| 100 | MP0001986_abnormal_taste_sensitivity | 0.64558759 |
| 101 | MP0001216_abnormal_epidermal_layer | 0.63884052 |
| 102 | MP0001851_eye_inflammation | 0.63082600 |
| 103 | MP0002095_abnormal_skin_pigmentation | 0.62323101 |
| 104 | MP0004883_abnormal_blood_vessel | 0.61146304 |
| 105 | MP0005167_abnormal_blood-brain_barrier | 0.61126333 |
| 106 | MP0003453_abnormal_keratinocyte_physiol | 0.60825524 |
| 107 | MP0010386_abnormal_urinary_bladder | 0.60491505 |
| 108 | MP0005319_abnormal_enzyme/_coenzyme | 0.60480311 |
| 109 | MP0000383_abnormal_hair_follicle | 0.59624986 |
| 110 | MP0001663_abnormal_digestive_system | 0.59285268 |
| 111 | MP0003795_abnormal_bone_structure | 0.59069509 |
| 112 | MP0001346_abnormal_lacrimal_gland | 0.58854730 |
| 113 | MP0000249_abnormal_blood_vessel | 0.57680099 |
| 114 | MP0003866_abnormal_defecation | 0.57048353 |
| 115 | MP0009765_abnormal_xenobiotic_induced | 0.56927300 |
| 116 | MP0003806_abnormal_nucleotide_metabolis | 0.56851070 |
| 117 | MP0000604_amyloidosis | 0.56833577 |
| 118 | MP0002693_abnormal_pancreas_physiology | 0.56625563 |
| 119 | MP0002876_abnormal_thyroid_physiology | 0.56243666 |
| 120 | MP0002396_abnormal_hematopoietic_system | 0.55553800 |
| 121 | MP0005075_abnormal_melanosome_morpholog | 0.54156259 |
| 122 | MP0000465_gastrointestinal_hemorrhage | 0.54047347 |
| 123 | MP0008004_abnormal_stomach_pH | 0.52455484 |
| 124 | MP0003091_abnormal_cell_migration | 0.51123619 |
| 125 | MP0003195_calcinosis | 0.50416554 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.67728842 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.52471395 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.19971402 |
| 4 | Increased IgM level (HP:0003496) | 4.66223829 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 4.56183566 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.35713885 |
| 7 | Optic neuritis (HP:0100653) | 4.34015741 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 4.34015741 |
| 9 | Loss of speech (HP:0002371) | 4.32493594 |
| 10 | Chronic otitis media (HP:0000389) | 4.30407635 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.30369800 |
| 12 | Orchitis (HP:0100796) | 4.17768517 |
| 13 | Myositis (HP:0100614) | 4.06953797 |
| 14 | Abnormality of macrophages (HP:0004311) | 3.97541539 |
| 15 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.96899018 |
| 16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.96899018 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 3.96899018 |
| 18 | Recurrent fungal infections (HP:0002841) | 3.95764180 |
| 19 | Vasculitis (HP:0002633) | 3.93066579 |
| 20 | Autoimmune thrombocytopenia (HP:0001973) | 3.88221184 |
| 21 | Recurrent skin infections (HP:0001581) | 3.87719540 |
| 22 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.80817513 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 3.80817513 |
| 24 | Basal ganglia calcification (HP:0002135) | 3.79201146 |
| 25 | Recurrent viral infections (HP:0004429) | 3.71202071 |
| 26 | Stomatitis (HP:0010280) | 3.60712194 |
| 27 | Prostate neoplasm (HP:0100787) | 3.55767965 |
| 28 | Chronic obstructive pulmonary disease (HP:0006510) | 3.41403277 |
| 29 | Obstructive lung disease (HP:0006536) | 3.41403277 |
| 30 | Gingivitis (HP:0000230) | 3.36730649 |
| 31 | Hypergammaglobulinemia (HP:0010702) | 3.32525870 |
| 32 | Meningitis (HP:0001287) | 3.08185671 |
| 33 | Autoimmune hemolytic anemia (HP:0001890) | 3.07141019 |
| 34 | Vacuolated lymphocytes (HP:0001922) | 3.06543620 |
| 35 | Recurrent bronchitis (HP:0002837) | 3.03169536 |
| 36 | Pulmonary infiltrates (HP:0002113) | 2.96367422 |
| 37 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.92526783 |
| 38 | Chronic sinusitis (HP:0011109) | 2.91873516 |
| 39 | Gingival bleeding (HP:0000225) | 2.89741617 |
| 40 | Gastrointestinal infarctions (HP:0005244) | 2.85209558 |
| 41 | Malnutrition (HP:0004395) | 2.84610622 |
| 42 | Nasal polyposis (HP:0100582) | 2.84222691 |
| 43 | Hemoptysis (HP:0002105) | 2.82717524 |
| 44 | Dysostosis multiplex (HP:0000943) | 2.76325775 |
| 45 | Recurrent pneumonia (HP:0006532) | 2.72520013 |
| 46 | Abnormality of T cell number (HP:0011839) | 2.70777783 |
| 47 | Periodontitis (HP:0000704) | 2.67059915 |
| 48 | Porencephaly (HP:0002132) | 2.64862909 |
| 49 | Thick nail (HP:0001805) | 2.63426438 |
| 50 | Agammaglobulinemia (HP:0004432) | 2.56893351 |
| 51 | Leukocytosis (HP:0001974) | 2.55570181 |
| 52 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.52573570 |
| 53 | Hematochezia (HP:0002573) | 2.52436645 |
| 54 | Systemic lupus erythematosus (HP:0002725) | 2.52070719 |
| 55 | Eosinophilia (HP:0001880) | 2.51797332 |
| 56 | Premature loss of primary teeth (HP:0006323) | 2.50672116 |
| 57 | Abnormality of the nasal mucosa (HP:0000433) | 2.49868667 |
| 58 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.48799673 |
| 59 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.46252312 |
| 60 | Keratoconjunctivitis sicca (HP:0001097) | 2.45000289 |
| 61 | T lymphocytopenia (HP:0005403) | 2.44471416 |
| 62 | Abnormality of the prostate (HP:0008775) | 2.44322244 |
| 63 | Chronic diarrhea (HP:0002028) | 2.42575524 |
| 64 | Arterial thrombosis (HP:0004420) | 2.42533272 |
| 65 | Recurrent lower respiratory tract infections (HP:0002783) | 2.40352996 |
| 66 | Osteomyelitis (HP:0002754) | 2.35601934 |
| 67 | IgG deficiency (HP:0004315) | 2.34704604 |
| 68 | Cellulitis (HP:0100658) | 2.34624732 |
| 69 | Progressive neurologic deterioration (HP:0002344) | 2.32190523 |
| 70 | Cheilitis (HP:0100825) | 2.31769099 |
| 71 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.31566033 |
| 72 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.31566033 |
| 73 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.31566033 |
| 74 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.31422310 |
| 75 | Abnormality of eosinophils (HP:0001879) | 2.29134964 |
| 76 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.28797879 |
| 77 | Polyneuropathy (HP:0001271) | 2.28430111 |
| 78 | Anorexia (HP:0002039) | 2.28195327 |
| 79 | Keratoconjunctivitis (HP:0001096) | 2.27577867 |
| 80 | Joint hemorrhage (HP:0005261) | 2.27274111 |
| 81 | Increased IgE level (HP:0003212) | 2.25778272 |
| 82 | Tetraparesis (HP:0002273) | 2.25499333 |
| 83 | Abnormality of the pericardium (HP:0001697) | 2.25127731 |
| 84 | Encephalitis (HP:0002383) | 2.23828271 |
| 85 | Urticaria (HP:0001025) | 2.23103666 |
| 86 | Pustule (HP:0200039) | 2.22902351 |
| 87 | Chromsome breakage (HP:0040012) | 2.21514813 |
| 88 | Thyroiditis (HP:0100646) | 2.20288750 |
| 89 | Abnormality of the endocardium (HP:0004306) | 2.20208218 |
| 90 | Mucopolysacchariduria (HP:0008155) | 2.20020951 |
| 91 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.20020951 |
| 92 | Joint swelling (HP:0001386) | 2.19236796 |
| 93 | Abnormality of T cells (HP:0002843) | 2.18604245 |
| 94 | Episodic fever (HP:0001954) | 2.17762234 |
| 95 | Apathy (HP:0000741) | 2.15993402 |
| 96 | Granulocytopenia (HP:0001913) | 2.14080259 |
| 97 | Glomerulonephritis (HP:0000099) | 2.12323344 |
| 98 | Severe combined immunodeficiency (HP:0004430) | 2.11332458 |
| 99 | Gangrene (HP:0100758) | 2.10694985 |
| 100 | Parakeratosis (HP:0001036) | 2.10394718 |
| 101 | Epistaxis (HP:0000421) | 2.07409700 |
| 102 | Diminished motivation (HP:0000745) | 2.07244810 |
| 103 | Abnormality of the basal ganglia (HP:0002134) | 2.07002255 |
| 104 | Clubbing of toes (HP:0100760) | 2.02457797 |
| 105 | Vertigo (HP:0002321) | 2.01485845 |
| 106 | Spontaneous hematomas (HP:0007420) | 2.00366507 |
| 107 | Inflammation of the large intestine (HP:0002037) | 2.00295054 |
| 108 | Conjunctival telangiectasia (HP:0000524) | 1.99488409 |
| 109 | Abnormality of B cell number (HP:0010975) | 1.99442618 |
| 110 | Disinhibition (HP:0000734) | 1.98546278 |
| 111 | Abnormality of the pleura (HP:0002103) | 1.97850580 |
| 112 | Gastrointestinal stroma tumor (HP:0100723) | 1.97727558 |
| 113 | Recurrent sinusitis (HP:0011108) | 1.97708119 |
| 114 | Keratitis (HP:0000491) | 1.97591205 |
| 115 | Pulmonary embolism (HP:0002204) | 1.96821138 |
| 116 | Interstitial pulmonary disease (HP:0006530) | 1.96141209 |
| 117 | Alveolar cell carcinoma (HP:0006519) | 1.96091338 |
| 118 | IgA deficiency (HP:0002720) | 1.95972708 |
| 119 | Abnormality of T cell physiology (HP:0011840) | 1.95047668 |
| 120 | Prolonged bleeding time (HP:0003010) | 1.93313213 |
| 121 | Nausea (HP:0002018) | 1.93167156 |
| 122 | Purpura (HP:0000979) | 1.92818631 |
| 123 | Colitis (HP:0002583) | 1.92386472 |
| 124 | Petechiae (HP:0000967) | 1.90850947 |
| 125 | Lymphopenia (HP:0001888) | 1.90023537 |
| 126 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.89974205 |
| 127 | Increased cerebral lipofuscin (HP:0011813) | 1.89560730 |
| 128 | Panhypogammaglobulinemia (HP:0003139) | 1.89417357 |
| 129 | Anhidrosis (HP:0000970) | 1.88388429 |
| 130 | Neurofibrillary tangles (HP:0002185) | 1.88204171 |
| 131 | Glomerulopathy (HP:0100820) | 1.87401810 |
| 132 | Myocardial infarction (HP:0001658) | 1.84862569 |
| 133 | Hepatosplenomegaly (HP:0001433) | 1.84404897 |
| 134 | Cleft eyelid (HP:0000625) | 1.83696975 |
| 135 | Combined immunodeficiency (HP:0005387) | 1.79762735 |
| 136 | Nephritis (HP:0000123) | 1.79712953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.55565028 |
| 2 | TYK2 | 3.76641816 |
| 3 | IKBKE | 3.56822077 |
| 4 | IRAK4 | 3.38888209 |
| 5 | TXK | 3.18004171 |
| 6 | IRAK3 | 3.09411600 |
| 7 | PBK | 3.03293537 |
| 8 | JAK3 | 2.89328299 |
| 9 | BLK | 2.77573667 |
| 10 | TBK1 | 2.76294715 |
| 11 | RIPK4 | 2.76117146 |
| 12 | JAK1 | 2.74974487 |
| 13 | MAP3K13 | 2.48831293 |
| 14 | KIT | 2.38518947 |
| 15 | RIPK1 | 2.36923970 |
| 16 | IKBKB | 2.25035226 |
| 17 | FGFR4 | 2.12806084 |
| 18 | MAP4K1 | 1.98250360 |
| 19 | EIF2AK2 | 1.85956385 |
| 20 | PRPF4B | 1.81280781 |
| 21 | TNIK | 1.68005883 |
| 22 | IRAK1 | 1.57706420 |
| 23 | TAOK2 | 1.54690628 |
| 24 | MAP3K3 | 1.53903111 |
| 25 | CASK | 1.52260129 |
| 26 | TAOK3 | 1.51439345 |
| 27 | CSK | 1.51148546 |
| 28 | MAP3K9 | 1.42399274 |
| 29 | FGFR3 | 1.41073087 |
| 30 | STK24 | 1.35744604 |
| 31 | PIM2 | 1.33451527 |
| 32 | NLK | 1.30389562 |
| 33 | EPHA3 | 1.30297744 |
| 34 | TAOK1 | 1.29774902 |
| 35 | CHUK | 1.29748743 |
| 36 | TEC | 1.25163829 |
| 37 | EPHB1 | 1.23378588 |
| 38 | BMPR2 | 1.22638381 |
| 39 | SYK | 1.19713450 |
| 40 | FES | 1.19699038 |
| 41 | YES1 | 1.17997470 |
| 42 | CDC42BPA | 1.16247727 |
| 43 | ZAP70 | 1.14437902 |
| 44 | LCK | 1.13709135 |
| 45 | MAP2K3 | 1.12722809 |
| 46 | NME2 | 1.12207826 |
| 47 | HCK | 1.11569975 |
| 48 | MST4 | 1.11017338 |
| 49 | LYN | 1.10137522 |
| 50 | DDR2 | 1.07734638 |
| 51 | MUSK | 1.07177043 |
| 52 | IRAK2 | 1.06710241 |
| 53 | NEK9 | 1.00775743 |
| 54 | ADRBK2 | 1.00346889 |
| 55 | BTK | 0.99956168 |
| 56 | SIK2 | 0.98861659 |
| 57 | MAP3K1 | 0.90542806 |
| 58 | MAP3K11 | 0.85475488 |
| 59 | CLK1 | 0.84836241 |
| 60 | STK4 | 0.81952892 |
| 61 | FGR | 0.80849001 |
| 62 | JAK2 | 0.79822975 |
| 63 | PKN1 | 0.77779269 |
| 64 | GRK7 | 0.77629802 |
| 65 | TESK2 | 0.77573063 |
| 66 | CSF1R | 0.77525711 |
| 67 | SIK3 | 0.76831565 |
| 68 | PRKCQ | 0.76179228 |
| 69 | STK16 | 0.75703885 |
| 70 | BMPR1B | 0.74645757 |
| 71 | PIM1 | 0.73309395 |
| 72 | ERN1 | 0.72861572 |
| 73 | NUAK1 | 0.71557172 |
| 74 | MARK3 | 0.69561716 |
| 75 | TGFBR2 | 0.67554243 |
| 76 | INSRR | 0.63962951 |
| 77 | CDK9 | 0.62200895 |
| 78 | GRK1 | 0.57428866 |
| 79 | KSR2 | 0.56396283 |
| 80 | GRK6 | 0.55847970 |
| 81 | MATK | 0.55832427 |
| 82 | MAPK7 | 0.55824428 |
| 83 | PDK1 | 0.53565118 |
| 84 | MAPK11 | 0.52890717 |
| 85 | ABL1 | 0.52347261 |
| 86 | TNK2 | 0.52121871 |
| 87 | MELK | 0.51711710 |
| 88 | MAPKAPK3 | 0.49732315 |
| 89 | TLK1 | 0.47203369 |
| 90 | PRKCD | 0.47077028 |
| 91 | RPS6KA5 | 0.46928240 |
| 92 | ACVR1B | 0.43569965 |
| 93 | TRPM7 | 0.43102159 |
| 94 | NEK6 | 0.43008560 |
| 95 | MAP2K6 | 0.40547257 |
| 96 | BRAF | 0.39031830 |
| 97 | MKNK2 | 0.38643468 |
| 98 | CAMKK2 | 0.37595559 |
| 99 | MST1R | 0.37257810 |
| 100 | ARAF | 0.36602899 |
| 101 | ITK | 0.34720660 |
| 102 | RAF1 | 0.34158849 |
| 103 | HIPK2 | 0.31915642 |
| 104 | ABL2 | 0.31633252 |
| 105 | PDPK1 | 0.31449940 |
| 106 | EGFR | 0.31369882 |
| 107 | TYRO3 | 0.31212003 |
| 108 | MAP3K5 | 0.30282987 |
| 109 | RPS6KA4 | 0.29242911 |
| 110 | PLK4 | 0.29167834 |
| 111 | PIK3CG | 0.28380370 |
| 112 | FYN | 0.26169860 |
| 113 | KSR1 | 0.25673703 |
| 114 | STK38 | 0.25276934 |
| 115 | PRKCE | 0.24029667 |
| 116 | MAP3K6 | 0.23511533 |
| 117 | STK10 | 0.22929919 |
| 118 | IGF1R | 0.22592451 |
| 119 | PRKD2 | 0.22035382 |
| 120 | LRRK2 | 0.21221893 |
| 121 | MAPK4 | 0.20915758 |
| 122 | BMX | 0.20318349 |
| 123 | ZAK | 0.19883620 |
| 124 | PRKCI | 0.19561669 |
| 125 | PDGFRB | 0.19046600 |
| 126 | SGK1 | 0.17758225 |
| 127 | TIE1 | 0.15364969 |
| 128 | INSR | 0.15325540 |
| 129 | SGK2 | 0.14342968 |
| 130 | MAPK3 | 0.13879155 |
| 131 | DAPK2 | 0.13873434 |
| 132 | MOS | 0.13812106 |
| 133 | MAPK12 | 0.13290804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.49950387 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.41652948 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.20998670 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.05994110 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.02245063 |
| 6 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 3.01638131 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.98998543 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.90627064 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.58393268 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.58060593 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.48595523 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.35222137 |
| 13 | Influenza A_Homo sapiens_hsa05164 | 2.32629060 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.23937542 |
| 15 | Malaria_Homo sapiens_hsa05144 | 2.21049084 |
| 16 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.14563122 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 2.03682246 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.01551793 |
| 19 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.93946080 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.92166325 |
| 21 | Legionellosis_Homo sapiens_hsa05134 | 1.90783145 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.85153035 |
| 23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.84050814 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.82850929 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.78854108 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.69598645 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.69099812 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.64065530 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.57722073 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.51827134 |
| 31 | Hepatitis C_Homo sapiens_hsa05160 | 1.45281320 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.35218439 |
| 33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.34843507 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30363812 |
| 35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.27759800 |
| 36 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.24008191 |
| 37 | Salmonella infection_Homo sapiens_hsa05132 | 1.22688415 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.15771497 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.13978107 |
| 40 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.07674539 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 0.97905770 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 0.95523740 |
| 43 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.93459354 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.90071682 |
| 45 | Lysosome_Homo sapiens_hsa04142 | 0.84584358 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81402697 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.79322001 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 0.75891096 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73843104 |
| 50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70793922 |
| 51 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65170463 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64992914 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 0.62320028 |
| 54 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61594534 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59577708 |
| 56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58678018 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56242283 |
| 58 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55868327 |
| 59 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.55013300 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54823746 |
| 61 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54554216 |
| 62 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53852212 |
| 63 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.52026545 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.46412705 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.45495991 |
| 66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43547905 |
| 67 | Insulin resistance_Homo sapiens_hsa04931 | 0.42647307 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40943624 |
| 69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.38474904 |
| 70 | Bladder cancer_Homo sapiens_hsa05219 | 0.38063116 |
| 71 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.37724658 |
| 72 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.36614815 |
| 73 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.36311941 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 0.35916977 |
| 75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.35570201 |
| 76 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.34766483 |
| 77 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.34422861 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.34400527 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34136204 |
| 80 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33402850 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31598779 |
| 82 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30902282 |
| 83 | Mineral absorption_Homo sapiens_hsa04978 | 0.30285758 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30090819 |
| 85 | Prion diseases_Homo sapiens_hsa05020 | 0.30047772 |
| 86 | Platelet activation_Homo sapiens_hsa04611 | 0.29151821 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28716267 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28039558 |
| 89 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.27881727 |
| 90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27771755 |
| 91 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.25395801 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24259838 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.24061646 |
| 94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.23088464 |
| 95 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.22696794 |
| 96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.21017265 |
| 97 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.20574695 |
| 98 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.20332838 |
| 99 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.20210435 |
| 100 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.19848792 |
| 101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.19811994 |
| 102 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.19630871 |
| 103 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.19380503 |
| 104 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.19191905 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.18098661 |
| 106 | Homologous recombination_Homo sapiens_hsa03440 | 0.17609455 |
| 107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.17157805 |
| 108 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.15455700 |
| 109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.12744971 |
| 110 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.12100066 |
| 111 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.11491086 |
| 112 | Histidine metabolism_Homo sapiens_hsa00340 | 0.11230214 |
| 113 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.10484348 |
| 114 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.09658425 |
| 115 | HTLV-I infection_Homo sapiens_hsa05166 | 0.08973880 |
| 116 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.08938872 |
| 117 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.08690167 |
| 118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.05857638 |

